Purpose: To investigate whether dendritic cells (DC), which as profess
ional antigen presenting cells have the capacity to stimulate immune r
esponses against tumour associated antigens, are recruited into and ac
tivated within prostate cancer. Materials and Methods: Immunoenzyme an
d immunofluorescence labelling was used to identify leucocyte and DC s
ubsets within 15 cases of prostate cancer. Cell numbers were compared
with numbers in adjacent normal prostatic tissue. Total DC numbers wer
e identified as CD45(+) leucocytes not coexpressing any lineage specif
ic markers. The Langerhans cell (LC) subset was detected using anti CD
la staining and activated DC were identified by their expression of e
ither CD83, CD86 or CMRF44. Results: DC were found to represent a smal
l subset of leucocytes present in both benign and malignant prostatic
tissue. Statistically there were significantly less DC and LC in prost
ate cancer compared with normal prostatic tissue, While only a small s
ubset of DC expressed markers of activation in prostate cancer, this w
as significantly more than the virtual absence of activated DC in norm
al prostatic tissue. Conclusions: This is the first time that DC have
been studied in prostate cancer using the relatively new DC specific m
onoclonal antibodies CD83 and CMRF-44. These findings suggest that the
re is no active recruitment of DC into prostate cancer and those DC pr
esent are only minimally activated.